Search results
Showing 1456 to 1470 of 1688 results for carers
Upadacitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3733]
In development [GID-TA10597] Expected publication date: TBC
Atezolizumab with chemotherapy for untreated recurrent or advanced endometrial cancer [ID6417]
Discontinued [GID-TA11522]
Pegylated liposomal irinotecan in combination for untreated metastatic pancreatic cancer [ID6461]
In development [GID-TA11580] Expected publication date: TBC
NICE has developed a medtech innovation briefing (MIB) on point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease .
Otovent nasal balloon for otitis media with effusion (MIB59)
NICE has developed a medtech innovation briefing (MIB) on the Otovent nasal balloon for otitis media with effusion
Discontinued [GID-TA11179]
In development [GID-TA11310] Expected publication date: TBC
Two technologies recommended for people with chronic tic disorders and Tourette syndrome
Draft guidance issued for consultation recommends two technologies to help people manage their condition.
Bipolar, schizophrenia and other psychoses: care planning (IND143)
This indicator covers the percentage of patients with schizophrenia, bipolar affective disorder and other psychoses who have a comprehensive care plan documented in the record, in the preceding 12 months, agreed between individuals, their family and/or carers as applicable. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM108
Cardiovascular events (prevention, high risk) - anacetrapib [ID1164]
Discontinued [GID-TA11176]
Elivaldogene autotemcel for treating cerebral adrenoleukodystrophy [ID1284]
Discontinued [GID-HST10038]